These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 8622988)
1. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988 [TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907 [TBL] [Abstract][Full Text] [Related]
3. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719 [TBL] [Abstract][Full Text] [Related]
4. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393 [TBL] [Abstract][Full Text] [Related]
5. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633 [TBL] [Abstract][Full Text] [Related]
6. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964 [TBL] [Abstract][Full Text] [Related]
7. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Cheng JQ; Altomare DA; Klein MA; Lee WC; Kruh GD; Lissy NA; Testa JR Oncogene; 1997 Jun; 14(23):2793-801. PubMed ID: 9190895 [TBL] [Abstract][Full Text] [Related]
8. Frequent activation of AKT2 kinase in human pancreatic carcinomas. Altomare DA; Tanno S; De Rienzo A; Klein-Szanto AJ; Tanno S; Skele KL; Hoffman JP; Testa JR J Cell Biochem; 2002; 87(4):470-6. PubMed ID: 14735903 [TBL] [Abstract][Full Text] [Related]
9. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo. Shi XH; Liang ZY; Ren XY; Liu TH Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011 [TBL] [Abstract][Full Text] [Related]
10. Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion. Pu P; Kang C; Li J; Jiang H Tumour Biol; 2004; 25(4):172-8. PubMed ID: 15557754 [TBL] [Abstract][Full Text] [Related]
11. Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene. Altomare DA; Kozak CA; Sonoda G; Testa JR Cytogenet Cell Genet; 1996; 74(4):248-51. PubMed ID: 8976376 [TBL] [Abstract][Full Text] [Related]
12. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759 [TBL] [Abstract][Full Text] [Related]
13. Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy. Tang YC; Li Y; Qian GX World J Gastroenterol; 2001 Feb; 7(1):22-7. PubMed ID: 11819727 [TBL] [Abstract][Full Text] [Related]
14. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249 [TBL] [Abstract][Full Text] [Related]
15. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. Pu P; Kang C; Li J; Jiang H; Cheng J J Neurooncol; 2006 Jan; 76(1):1-11. PubMed ID: 16402276 [TBL] [Abstract][Full Text] [Related]
16. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461 [TBL] [Abstract][Full Text] [Related]
17. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743 [TBL] [Abstract][Full Text] [Related]
18. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736 [TBL] [Abstract][Full Text] [Related]
19. [Effects of antisense cyclin D1 expressing vector on the cell growth and apoptosis of pancreatic carcinoma]. Xu Y; Liu T; Gao J Zhonghua Bing Li Xue Za Zhi; 1998 Oct; 27(5):348-51. PubMed ID: 11245009 [TBL] [Abstract][Full Text] [Related]
20. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Burfeind P; Chernicky CL; Rininsland F; Ilan J; Ilan J Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7263-8. PubMed ID: 8692980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]